The COVID-19 outbreak struck the healthcare industry the worst of all. Stocks like AbbVie Inc. and Pfizer Inc. saw huge gains in the aftermath of the financial crisis. According to a Deloitte assessment of the healthcare sector’s 2021 prognosis, new technology and digital tools and services will boost the industry. In the second quarter of 2021, UnitedHealth Group, Incorporated achieved exceedingly encouraging results. Since March 2017, Insider Monkey’s research has discovered hedge fund holdings that have outperformed the S&P 500 by more than 124 percentage points.
Insider Monkey looks at the 10 best healthcare dividend stocks to buy now. CVS Health Corporation is ranked 10th. According to Thomson Reuters data, the company has gained 17.44% in the last six months and 22% year to date. AstraZeneca PLC was one of the earliest and most successful firms to develop and market a coronavirus vaccine. In a variety of medical fields, the business finds and manufactures prescription drugs. On the list of the best healthcare dividend stocks to purchase right now, it ranks 9th. Johnson & Johnson was one of the first and most successful pharmaceutical companies to develop a COVID-19 vaccine. On the list of the best healthcare dividend stocks to purchase right now, the company ranks eighth. Johnson & Johnson’s stock has an Overweight rating from Cantor Fitzgerald. National HealthCare Corporation is ranked seventh. According to Thomson Reuters, the company has gained 15.25 percent in the last six months and 12.10 percent year to date. Bristol-Myers Squibb Company comes in sixth. In the last six months, the company has gained 13.35 percent, and year to date, it has gained 11.89 percent. For more details, click 10 Best Healthcare Dividend Stocks To Buy Now.
Unsplash
